Novel pharmaceutical composition for prevention and control of liberobacter asiaticum

A citrus huanglongbing and composition technology, which is applied in the field of citrus disease prevention, can solve the problems of low citrus yield and sugar content, general taste and appearance color, short drug effect time, etc. Smooth, long-lasting effect

Inactive Publication Date: 2017-03-22
钟山佳欣果蔬有限责任公司
View PDF4 Cites 3 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0009] The invention provides a novel pharmaceutical composition for preventing and treating citrus huanglongbing to solve the problem of the existing biopesticides, which have short drug action time and poor effect, and the existing drugs for preventing and treating citrus huanglongbing have improved citrus yield and sugar content rate after use. Problems such as low quality, general taste and appearance color

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

preparation example Construction

[0067] The preparation method of the pharmaceutical composition for preventing and treating citrus Huanglongbing comprises the following steps:

[0068] S1: Mix Patrinia, maple poplar leaves, mint, magnolia bark, neem, bitter bark vine, ailanthus, and lettuce to obtain mixture I, and add mixture I to ethanol, and the ratio of solid to liquid is 1:14-16 , the ultrasonic power is 200-300W, the ethanol concentration is 65%-80%, the extraction temperature is 66-72°C and the medicinal solution is extracted for 18-24min to obtain the medicinal solution;

[0069] S2: passing the liquid medicine prepared in step S1 through a 3000-5000 mesh sieve to obtain a filtrate;

[0070] S3: adding potassium salt, phosphorus salt, nitrogen salt, calcium salt, magnesium salt, iodine salt, boron salt, molybdenum salt, zinc salt, manganese salt, copper salt, iron salt, vitamin, amino acid, Indole butyric acid, gibberellin, 6-benzyl adenine, naphthalene acetic acid, agar, kinetin, polyvinylpyrrolido...

Embodiment 1

[0076] A novel pharmaceutical composition for preventing and treating citrus huanglongbing, comprising the following raw materials in parts by weight: 135 parts of Patrinia, 110 parts of maple poplar leaves, 100 parts of peppermint, 90 parts of Magnolia officinalis, 75 parts of neem, and bitter bark vine 70 parts, 70 parts of Ailanthus sinensis, 55 parts of lettuce, 2.5 parts of potassium salt, 2 parts of phosphorus salt, 1.5 parts of nitrogen salt, 0.8 part of calcium salt, 0.8 part of magnesium salt, 0.3 part of iodine salt, 0.3 part of boron salt, 0.3 part of molybdenum salt , 0.3 parts of zinc salt, 0.3 part of manganese salt, 0.3 part of copper salt, 0.3 part of iron salt, 0.3 part of vitamin, 0.2 part of amino acid, 0.08 part of indole butyric acid, 0.08 part of gibberellin, 0.07 part of 6-benzyl adenine 0.05 parts of naphthalene acetic acid, 0.2 parts of agar, 0.05 parts of kinetin, 1.6 parts of polyvinylpyrrolidone, 1.2 parts of sodium methylene bis-naphthalene sulfonat...

Embodiment 2

[0106] A novel pharmaceutical composition for preventing and treating citrus huanglongbing, comprising the following raw materials in parts by weight: 122 parts of Patrinia, 104 parts of maple poplar leaves, 93 parts of mint, 82 parts of Magnolia officinalis, 65 parts of neem, and bitter bark vine 55 parts, 52 parts of Ailanthus sinensis, 45 parts of lettuce, 2 parts of potassium salt, 1 part of phosphorus salt, 1 part of nitrogen salt, 0.6 part of calcium salt, 0.6 part of magnesium salt, 0.2 part of iodine salt, 0.2 part of boron salt, 0.2 part of molybdenum salt , 0.2 parts of zinc salt, 0.2 part of manganese salt, 0.2 part of copper salt, 0.2 part of iron salt, 0.2 part of vitamin, 0.2 part of amino acid, 0.06 part of indole butyric acid, 0.06 part of gibberellin, 0.06 part of 6-benzyl adenine 0.04 parts of naphthalene acetic acid, 0.1 parts of agar, 0.04 parts of kinetin, 0.8 parts of polyvinylpyrrolidone, 0.6 parts of sodium methylene bis-naphthalene sulfonate, 1 part of ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses a novel pharmaceutical composition for prevention and control of liberobacter asiaticum, wherein the pharmaceutical composition comprises the following raw materials: herba patriniae, pterocarya stenoptera leaves, mint, mangnolia officinalis, melia azedarach, celasturs angulatus maxim, ailanthus altissima, lettuce, sylvite, phosphorus salt, nitrogen salt, calcium salt, magnesium salt, iodised salt, boron salt, molybdenum salt, zinc salt, manganese salt, copper salt, iron salt, vitamins, amino acids, indolebutyric acid, gibberellin, 6-benzylaminopurine, naphthylacetic acid, agar, kinetin, polyvinylpyrrolidone, sodium methylene bis-naphthalene sulfonate, an American DuPont EEA2112AC compatibilizer, an ampullaria gigas powder, alkyl potassium sulfate, acrylate, glycidoxypropyltrimethoxysilane, xanthan gum, and ethanol. The pharmaceutical composition for prevention and control of liberobacter asiaticum can increase the yield and the sugar content; citrus reticulata blanco has the advantages of good taste, mellow and full appearance and color, and high quality; and the pharmaceutical composition has the use effect higher than that of a conventional pharmaceutical composition for prevention and control of liberobacter asiaticum.

Description

[0001] 【Technical field】 [0002] The invention belongs to the technical field of citrus disease prevention, and in particular relates to a novel pharmaceutical composition for preventing and treating citrus huanglongbing. [0003] 【Background technique】 [0004] Citrus (Citrus reticulata Blanco) belongs to the Rutaceae plant. It likes a warm and humid climate, and its cold resistance is slightly stronger than pomelo, lime, and sweet orange. The Rutaceae citrus subfamily is distributed at 16°-37° north latitude. It is a tropical and subtropical evergreen fruit tree (except Citrus aurantium), and there are 3 genera used for economic cultivation: Citrus Citrus, Citrus and Kumquat. The citrus cultivated in China and other countries of the world is mainly of the Citrus genus. [0005] Citrus huanglongbing is a systemic disease, commonly known as the "cancer" of citrus. There is no cure for it, and the only option is to cut down the tree after infection. A devastating disease of...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A01N65/26A01N59/26A01N59/20A01N59/16A01N59/14A01N59/12A01N59/06A01N43/90A01N43/78A01N43/38A01N43/12A01N37/10A01N31/04A01N43/08A01N37/44A01N43/36A01P1/00A01P7/04A01P21/00
CPCA01N65/00A01N31/04A01N37/10A01N37/44A01N43/08A01N43/12A01N43/36A01N43/38A01N43/78A01N43/90A01N59/06A01N59/12A01N59/14A01N59/16A01N59/20A01N59/26A01N65/26A01N2300/00
Inventor 杨龙俊
Owner 钟山佳欣果蔬有限责任公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap